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Available online 3 June 2013The precise regulation of gene expression is critical to the nor-
mal development and biological function of all organisms.
Dysregulation of gene expression during early development
can result in a spectrum of failures ranging from minor defects
to the termination of development. In adult life, dysregulation
can lead to the uncontrolled cell proliferation of cancer or pro-
grammed cell death leading to neurodegenerative diseases. The
regulation of gene expression is controlled by multiple systems
with more being discovered. The immediate regulators are
transcription factors which bind to speciﬁc sequences in the
promoter or enhancer regions of individual genes. The activity
of transcription factors can be regulated by the presence of
other transcription factors and cofactors, methylation status
of the promoter or enhancer region, accessibility of the DNA
due to the local compactness of the chromatin and various
modiﬁcations of the histone tails. Transcribed mRNAs are
then subject to degradation before being translated into
protein products, during which microRNAs play a major role
[1]. In this special issue, we present recent advances in the
elucidation of gene regulatory networks (GRNs).
After the completion of the human genome project, people
realized that even excluding the repetitive sequences, protein
coding regions are only a small portion of the whole genome.
To explore the functional roles of the ‘‘junk’’ regions, the
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erated vast amounts of functional data for non-protein coding
regions over the past 10 years. In this issue, Qu and Fang
provide a short review of the history and current status of
the ENCODE project [2].
Enhancers are DNA elements directly involved in the regu-
lation of gene expression. Enhancers can be located near cod-
ing regions or far away. The activity of enhancers with respect
to gene expression depends on the speciﬁc tissues and/or devel-
opmental stages, as a consequence of the presence or absence
of transcription factors and the epigenetic modiﬁcations of
the enhancers themselves. In this issue, Wang et al. review
computational efforts to identify spatially and temporally ac-
tive enhancers using the recently available ENCODE data [3].
The activity of enhancers requires the presence of mediator
complexes. Mediator complexes are large protein complexes
which bind to transcription factors, RNA polymerase II and
various transcription regulators such as non-coding RNAs.
Mediator complexes are essential for transcription, and defects
in mediator complexes have been associated with severe dis-
eases. In this issue, Grueter presents a review of the role of
mediator complexes in cardiac development and disease [4].
We have also included two original research articles in this
special issue. Bickhart and Liu use a bioinformatics approach
to identify approximately 380,000 putative transcription factor
binding sites in the cattle genome, validating a subset of them
and demonstrating their speciﬁcity [5]. This work paves the
way for comparison of GRNs between cattle and other mam-
malian model systems. In order to construct complex interac-
tion and regulatory networks, Sun et al. incorporate
information from multiple sources, including protein-protein
interaction databases, pathway databases, transcription factor
target gene predictions and microRNA target gene predictions
to generate regulatory networks from an input gene set [6].cademy of Sciences and Genetics Society of China. Production and hosting
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tion, Li et al. present a summary of the discovery of biomark-
ers for lupus nephritis from serum and urine employing
genomic approaches [7].
The elucidation and study of GRNs is a fast evolving ﬁeld.
Recently, RNA methylation has emerged as yet another layer
of regulation [8]. With the rapid development and application
of genomic technologies, we anticipate that many new layers of
regulatory complexity will emerge. In the meantime, it be-
comes increasingly important to understand the complex rela-
tionships between genes and how changes in GRNs can result
in phenotypic change.Acknowledgements
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